Table 3.

IgG ratios of Globo H analogs to Gb5 from breast cancer patients (n = 58) and healthy individuals (n = 47)

IgG ratio, %	GH/Gb5		Bb4/Gb5		Bb3/Gb5		Bb2/Gb5
	Healthy	Cancer	Healthy	Cancer	Healthy	Cancer	Healthy	Cancer
Mean	26.92	58.31	11.91	17.84	15.22	22.54	78.02	120.8
SD	18.49	31.14	20.54	19.60	23.12	23.22	63.63	92.26
P	P < 0.0001***		0.1360 (ns)		0.1106 (ns)		0.0063**

***, P < 0.001, extremely significant; **, P = 0.001–0.01, very significant; ns, P < 0.05, not significant.